This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of dermatophyte onychomycosis

Authoring team

Consider treatments for:

  • distal and localised nail disease

  • more proximal or extensive onychomycosis

Treat only if infection confirmed by laboratory

  • only use topical treatment if superficial infection of the top surface of nail plate For infections with dermatophytes use oral terbinafine or itraconazole
  • for infections with candida or non-dermatophyte moulds use oral itraconazole
  • idiosyncratic liver and other severe reactions occur very rarely with terbinafine and itraconazole
  • for children seek expert advice

Treatments available (1,2)

  • 5% amorolfine nail lacquer
    • 1-2x/weekly
      • fingers for 6 months
      • toes for 12 months
  • terbinafine
    • 250 mg OD
      • fingers for 6-12 weeks
      • toes for 3-6 months
  • itraconazole
    • 200 mg BD
      • fingers for 2 courses of 7 days/month
      • toes for 3 courses of 7 days/month

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.